Federated Hermes, Inc. Travere Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$50.2 Billion
Q2 2025

A detailed history of Federated Hermes, Inc. transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 527,538 shares of TVTX stock, worth $13.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

527,538

Previous 672,648 21.57%

Holding current value

$13.8 Million

Previous $12.1 Million 35.23%

% of portfolio

0.02%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$13.49 - $21.54 $1.96 Million - $3.13 Million	-145,110 Reduced 21.57%	527,538 $7.81 Million
Q1 2025 May 08, 2025	BUY	$17.07 - $23.75 $73,964 - $102,908	4,333 Added 0.65%	672,648 $12.1 Million
Q4 2024 Feb 13, 2025	BUY	$13.65 - $19.85 $607,425 - $883,325	44,500 Added 7.13%	668,315 $11.6 Million
Q3 2024 Nov 13, 2024	BUY	$7.89 - $15.21 $4.59 Million - $8.85 Million	582,098 Added 1395.35%	623,815 $8.73 Million
Q2 2024 Aug 08, 2024	BUY	$5.26 - $8.28 $219,431 - $345,416	41,717 New	41,717 $342,000
Q3 2023 Nov 13, 2023	BUY	$7.64 - $17.25 $744,831 - $1.68 Million	97,491 New	97,491 $871,000
Q4 2022 Feb 13, 2023	SELL	$18.47 - $26.14 $22,127 - $31,315	-1,198 Reduced 99.92%	1 $0
Q3 2022 Nov 14, 2022	BUY	$22.91 - $28.63 $9,599 - $11,995	419 Added 53.72%	1,199 $30,000
Q2 2022 Aug 15, 2022	SELL	$20.94 - $30.01 $1.8 Million - $2.59 Million	-86,154 Reduced 99.1%	780 $20,000
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $845,757 - $1.1 Million	35,822 Added 70.09%	86,934 $2.24 Million
Q4 2021 Feb 14, 2022	BUY	$24.34 - $31.17 $1.17 Million - $1.5 Million	47,971 Added 1527.25%	51,112 $1.59 Million
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $821,075 - $1.58 Million	-63,257 Reduced 95.27%	3,141 $76,000
Q2 2021 Aug 16, 2021	SELL	$14.11 - $26.4 $3.51 Million - $6.56 Million	-248,419 Reduced 78.91%	66,398 $969,000
Q1 2021 May 13, 2021	BUY	$23.37 - $31.77 $1.16 Million - $1.58 Million	49,583 Added 18.69%	314,817 $7.86 Million
Q4 2020 Feb 12, 2021	BUY	$19.17 - $27.87 $5.08 Million - $7.39 Million	265,234 New	265,234 $7.23 Million

Others Institutions Holding TVTX

# of Institutions

230

Shares Held

101M

Call Options Held

1.71M

Put Options Held

401K

View Full List

About Travere Therapeutics, Inc.

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.68B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

More about TVTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Travere Therapeutics, Inc. Transaction History